Precision medicine welcomes the golden age of Galaxy's biological layout at the right time
National policy accelerated With the development of modern biomedical technology, precision medicine has received more and more attention. Accurate treatment is based on personal genomic information, combined with proteomics, metabolomes and other related internal environmental information, to design a health management and disease treatment program for people to achieve maximum therapeutic effect and minimize side effects of a customized medical treatment the way. Professionals in the industry believe that there is a big difference between precision medicine and traditional medical methods. First of all, the diagnosis of precision medicine relies on genetic testing technology and big data analysis to understand the individual's health and potential disease, to plan health interventions for individuals, and to maximize the treatment effect through targeted drugs during disease diagnosis and treatment. And side effects are minimized. Since the concept of precision treatment was put forward, China has also attached great importance to the development of related industries. In 2015, the Ministry of Science and Technology plans to invest 60 billion yuan in precision medicine by 2030. On June 25 this year, the National Science and Technology Management Information System Public Service Platform issued the "Notice on Publicizing the 2016 Project Arrangement for the National Key Research and Development Program "Precision Medical Research", and publicized the key information items of 61 precision medicines. This is the beginning of the project in the field of precision medical research after China established the China Precision Medical Plan. In order to refine the implementation of the precise medical policy, the Ministry of Science and Technology also announced the “Notice of the Ministry of Science and Technology on the publication of the 2016 special project declaration guidelines for key national research and development programs, such as precision medical researchâ€, which firstly defined the application and business planning of precision medicine. , technology development, etc., which is regarded as a guide for the development of precision medicine in the industry. It is reported that the “Thirteenth Five-Year Plan†for biomedicine will be introduced in the second half of the year. According to the plan, during the “Thirteenth Five-Year Plan†period, China’s biomedical industry will focus on the development of major diseases such as chemical drugs, biotechnology drugs, new vaccines, and new cell therapy preparations. An innovative drug category, while developing major medical technologies such as bio 3D printing technology. The accelerated implementation of these policies and funds plays an important role in promoting the development of China's precision medical industry . Incomplete industrial chain or will constrain industry development Since 2015, private capital investment in the field of precision medicine has been hot and the market has been highly active. There are 26 listed companies in China, including gene sequencing , cell therapy and stem cells. China's outstanding precision medical industry companies such as Huada Gene, Zhongyuan Concord [-0.08% Research Report] have become more and more More attention from the market. However, the current scale of precision medical care in China is not large enough. We need more high-tech enterprises with independent intellectual property rights to grow up, and the scale of the industry can be expanded rapidly. Some industry experts believe that China's precision medical industry chain is still incomplete. Most of the enterprises in China are engaged in the gene sequencing industry. Most of the cost of each gene sequencing company is in equipment, reagents and other consumables. At present, the international and domestic market genetic sequencing equipment and consumables are monopolized by foreign manufacturers. In addition, in the field of subsequent bioinformatics analysis, because there is no relatively complete health database in China, data analysis and other aspects are also the majority of foreign manufacturers. Wang Jian, former chairman of Huada Gene, also told the media that in the field of genetic engineering, the biggest challenge is the database problem. In 10 years, the company spent about 1 billion US dollars on database construction, but the amount of data involved is too large. The decline in the price of related services within two years is not good. Public information display, currently in construction and precision of medical drug development and other aspects of large medical databases also relatively weak, building databases need to invest not only equipment, but also the clinical data collection terminals, storage and analysis. China has abundant clinical resources, and many institutions in China have established biological sample banks, but the resources of each institution are not shared with each other, and it is impossible to form effective resource opening and sharing, database establishment and subsequent big data storage. And analysis has created certain obstacles.
Hospital Ward Nursing System
Hopsital Management Wired Emergency Call System is an indispensable important part in hospital digitization construction,which not only provides the powerful communication among doctors, nurses,and patients,but also creatively offers the new functions of voice reminding, information issuing, information collection, information process, and etc, stretched hospital information system(His) to wards. This system has truly achieved a leap of nursing quality besides the greatly decrease of the work intensity of nursing staff.
Hospital Ward Nursing System,Wired Nurse Call Bell System,Nurse Call Bell System,Ward Nurse Call Bell System Hunan Eter Medical Co., Ltd. , https://www.eter-tech.com
